GHRP-2 Protocol: Complete Cycling & Dosing Guide

GHRP-2 Protocol: Complete Cycling & Dosing Guide

Overview

GHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic hexapeptide that functions as a ghrelin mimetic, triggering endogenous growth hormone secretion directly from the anterior pituitary. Unlike exogenous HGH administration, GHRP-2 works through your body's own regulatory systems, making it a viable option for those seeking to amplify natural GH pulses without introducing synthetic hormone.

The compound acts as a selective agonist at the ghrelin receptor (GHS-R1a), simultaneously suppressing somatostatin signaling to remove the "brakes" on GH release. This dual action creates strong, pulsatile GH surges—particularly when stacked with GHRH analogs. GHRP-2 also mildly elevates prolactin and cortisol, distinguishing it from cleaner secretagogues like Ipamorelin.

Important: This guide is educational content describing research protocols. GHRP-2 is not FDA-approved for human therapeutic use and is sold as a research chemical only. Consult a healthcare provider before use.

Standard Protocol

Dosing Foundation

The effective dose range for GHRP-2 is 100–300 mcg administered via subcutaneous or intramuscular injection, taken 2–3 times daily. Most practitioners begin at the lower end and titrate upward based on tolerance and response.

Beginner Protocol:

• 100 mcg, 2× daily (morning and evening)
• Total daily dose: 200 mcg
• Injection timing: Upon waking and 4–6 hours before bed
• Cycle duration: 12–16 weeks
• Rest period: 4–8 weeks off compound

Intermediate Protocol:

• 150 mcg, 3× daily (morning, midday, evening)
• Total daily dose: 450 mcg
• Injection timing: 8 AM, 1 PM, 7 PM
• Cycle duration: 12–16 weeks
• Rest period: 6–8 weeks off compound

Advanced Protocol:

• 200–300 mcg, 3× daily
• Total daily dose: 600–900 mcg
• Injection timing: Every 6–8 hours
• Cycle duration: 8–12 weeks (shorter cycles to manage cortisol/prolactin elevation)
• Rest period: 8–12 weeks off compound

Cycle Architecture

The optimal cycle follows a 12–16 week on, 6–12 week off structure. This periodization allows GH axis recovery, minimizes receptor downregulation, and prevents chronic elevation of cortisol and prolactin—the primary limiting factors with GHRP-2.

Why the off-cycle matters: Continuous GHRP-2 use drives compensatory feedback mechanisms. Taking 6–12 weeks completely off restores sensitivity and prevents the compound from becoming progressively less effective.

Goal-Specific Protocols

Fat Loss Protocol

Objective: Leverage GH's lipolytic properties while minimizing appetite stimulation.

GHRP-2 stimulates appetite dose-dependently (10.2% at low doses, 33.5% at high doses), which contradicts fat loss goals. To overcome this:

• Dose: 100 mcg, 2× daily (keep it low to minimize hunger)
• Timing: Inject 30 minutes before cardio/training
• Stacking: Combine with Ipamorelin (100 mcg, 3× daily) — Ipamorelin lacks the appetite stimulation while providing synergistic GH release
• Diet: Maintain strict caloric deficit; do not rely on GHRP-2 to create energy expenditure
• Cycle: 12 weeks on, 8 weeks off
• Training: 4–6 days per week; include 2–3 fasted cardio sessions weekly

Expected fat loss: Indirect and modest; GH elevation supports mobilization of visceral fat, but evidence is limited. Expect 0.5–1 lb per week with disciplined diet and training.

Muscle Growth Protocol

Objective: Maximize synergistic GH and IGF-1 elevation for myofibril hypertrophy.

• Dose: 150–200 mcg, 3× daily
• Stacking: GHRP-2 + GHRH (like Sermorelin 100–200 mcg, 1× daily at night) — this combination produces supraphysiological GH pulses
• Additional support: Testosterone or other anabolic agents amplify IGF-1 response (evidence shows 50% IGF-1 increase over 4 months with concurrent androgens)
• Training: Progressive resistance training, 5–6 days weekly with adequate protein (1.0–1.2g per lb bodyweight)
• Nutrition: Caloric surplus, high protein, micronutrient-dense
• Cycle: 12–16 weeks on, 8 weeks off
• Monitoring: Serum IGF-1 every 4–6 weeks; target 250–350 ng/mL

Expected gains: Animal evidence shows upregulation of muscle growth genes (PI3K, Akt, mTOR). Human data is limited but suggests 5–15 lb of lean mass per cycle with concurrent resistance training and androgens.

Injury Recovery & Joint Health Protocol

Objective: Exploit GH's tissue remodeling and anti-inflammatory effects.

• Dose: 100–150 mcg, 2–3× daily
• Stacking: GHRP-2 + BPC-157 (500 mcg, 1–2× daily) — BPC-157 shows synergistic tendon healing
• Timing: Inject at least one dose immediately post-training (when blood flow to injured tissue is elevated)
• Cycle: 8–12 weeks minimum; many practitioners extend to 16 weeks for severe injuries
• Mobility work: Daily dedicated stretching, mobility drills, soft tissue work
• Monitoring: Functional tests (ROM, strength testing, pain assessment) every 2 weeks

Rationale: GHRP-2 reduced M1 macrophage markers and improved tendon-bone healing in rat rotator cuff models. Anecdotal reports suggest improved recovery speed, but controlled human trials are absent.

Anti-Aging & Longevity Protocol

Objective: Maintain elevated GH and IGF-1 to support cellular regeneration.

• Dose: 100 mcg, 2–3× daily
• Stacking: GHRP-2 + Ipamorelin (100 mcg, 3× daily) — cleaner GH stimulation with less cortisol/prolactin elevation
• Cycle: 8 weeks on, 6 weeks off; repeated cyclically indefinitely
• Sleep: 7–9 hours nightly; GH release is sleep-dependent
• Stress management: Chronic cortisol elevation counteracts anti-aging benefits; prioritize stress mitigation
• Monitoring: IGF-1, cortisol, prolactin every 8–12 weeks

Reality check: Direct longevity data in humans is absent. GHRP-2 reliably elevates GH and IGF-1, but whether this extends healthspan or lifespan remains theoretical.

How to Administer Step-by-Step

Reconstitution (for lyophilized GHRP-2)

1. Supplies needed: Sterile bacteriostatic water (0.9% NaCl with benzyl alcohol), insulin syringe (29–31 gauge), sterile vial, alcohol swabs
2. Calculate dilution: Most GHRP-2 arrives as 5–10 mg lyophilized powder. Standard reconstitution is 1 mL per 1 mg (1 mg/mL concentration). For 5 mg: add 5 mL bacteriostatic water.
3. Reconstitution process:
   • Swab rubber stopper with alcohol; let dry 30 seconds
   • Draw 5 mL bacteriostatic water into syringe
   • Inject slowly into vial; do NOT shake (creates foam and denatures peptide)
   • Gently roll vial between palms for 60–90 seconds until powder fully dissolves

• Solution should be clear and colorless

4. Storage: Reconstituted GHRP-2 is stable for 30 days refrigerated (2–8°C); freeze at −20°C for longer storage (up to 6 months)

Injection Technique

1. Site selection: Subcutaneous injection into abdomen (lower belly, 2 inches from navel), thigh, or back of arm. Rotate sites daily to prevent lipohypertrophy.
2. Preparation:
   • Wash hands thoroughly
   • Swab injection site with alcohol; let dry 10 seconds
   • Draw dose into insulin syringe (e.g., 100 mcg = 0.1 mL at 1 mg/mL concentration)
3. Injection:
   • Pinch skin fold gently
   • Insert needle at 45–90° angle, approximately 0.25–0.5 inches deep (subcutaneous layer)
   • Inject slowly over 3–5 seconds
   • Withdraw needle and apply light pressure with alcohol swab
   • Massage gently for 10 seconds to aid absorption
4. Post-injection: No food or large calories for 15–30 minutes (fasting amplifies GH secretion; eating suppresses it)

Cycle Example: Week-by-Week Schedule

12-Week Intermediate Muscle-Building Cycle

What to Expect: Timeline of Effects

Days 1–3: Mild increased appetite (ghrelin mimesis), possible tingling in extremities, slight fatigue as axis adjusts.

Days 4–7: Appetite normalization if dose is low; some practitioners report improved sleep quality and recovery. Energy may dip slightly.

Weeks 2–3: Noticeable appetite stimulation (especially at ≥150 mcg doses). Sleep quality typically improves. First signs of enhanced recovery between training sessions.

Weeks 4–6: IGF-1 begins rising measurably (if checked via bloodwork). Mood may be slightly elevated. Some users report improved skin texture and hair growth (anecdotal, not proven).

Weeks 8–12: Maximum effect window. Lean mass accumulation accelerates (with proper training/nutrition). Water retention may become apparent at higher doses. Appetite remains elevated.

Post-cycle (weeks 13+): Hormonal normalization begins; expect 2–4 weeks of reduced appetite and slight energy dip as GH axis resets. Most gains retain if training and nutrition are maintained.

Adjustment markers:

• Appetite increasing excessively? Lower dose by 50 mcg or extend rest periods between doses.
• No appetite stimulation? Likely underdosed; increase by 50 mcg.
• Tingling/numbness persists beyond week 2? Reduce dose; consider adding Ipamorelin (cleaner profile) instead.
• Water retention worsening? Increase sodium intake strategically; ensure adequate potassium. If severe, lower dose.

Common Protocol Mistakes

1. Injecting too late in the day: GHRP-2 stimulates a GH pulse that lasts 30–60 minutes. Injecting after 8 PM can disrupt sleep quality. Keep last injection by 7 PM.

2. Eating immediately after injection: Food suppresses GH secretion via insulin. Wait 30 minutes post-injection before eating.

3. Using tap water or non-sterile reconstitution: Contamination leads to infections, abscess formation, and lost product. Use bacteriostatic water only.

4. Ignoring prolactin/cortisol elevation: GHRP-2 stimulates both. Long-term use without monitoring can cause gynecomastia (prolactin) and immunosuppression (cortisol). Check bloodwork every 8 weeks and take breaks.

5. Cycling too frequently: Running GHRP-2 indefinitely causes receptor downregulation and blunted response. Enforce 6–8 week rest periods minimum.

6. Exceeding 300 mcg per dose: Doses above this range don't produce proportionally greater GH release; they amplify side effects (appetite, water retention, cortisol, prolactin).

7. Stacking with incompatible compounds: GHRP-2 + Ipamorelin + GHRH (triple stack) can produce excessive cortisol elevation and blunt response due to negative feedback. Stick to GHRP-2 + one other compound (either Ipamorelin or GHRH).

8. Not rotating injection sites: Repeated injection into the same area causes lipohypertrophy (fat lumps) and reduced absorption. Rotate daily across 4–6 sites.

How to Stack with Other Compounds

GHRP-2 + GHRH (Sermorelin)

Rationale: Synergistic GH release. GHRP-2 works via ghrelin receptor; GHRH works via GHRH receptor—dual pathway activation.

Dosing:

• GHRP-2: 150 mcg, 2–3× daily
• Sermorelin: 100–150 mcg, 1× daily (typically bedtime)
• Result: 1.9–8.8× amplification of GH burst mass vs. GHRP-2 alone

Best for: Muscle growth, anti-aging protocols.

Caution: Cortisol and prolactin elevation is greater. Monitor hormone panels every 8 weeks.

GHRP-2 + Ipamorelin

Rationale: Ipamorelin is a selective GHS-R1a agonist without prolactin/cortisol elevation; stacking adds GH-releasing diversity.

Dosing:

• GHRP-2: 100 mcg, 2–3× daily
• Ipamorelin: 100 mcg, 3× daily
• Result: Robust GH release with cleaner hormonal profile

Best for: Fat loss, joint recovery, anti-aging (more conservative).

Advantage: Lower risk of side effects vs. GHRP-2 monotherapy.

GHRP-2 + Testosterone/Anabolics

Rationale: Androgens amplify IGF-1 response to GH stimulation (evidence shows 50% IGF-1 increase over 4 months).

Dosing:

• GHRP-2: 150–200 mcg, 3× daily
• Testosterone or equivalent: Standard TRT or performance dose
• Result: Enhanced myofibril recruitment and muscle protein synthesis

Best for: Muscle growth protocols in men.

Caution: Stacking